- Home
- DYN vs MTAL Comparison
DYN vs MTAL Comparison
Compare DYN & MTAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYN
- MTAL
- Stock Information
- Founded
- DYN 1984
- MTAL 2021
- Country
- DYN United States
- MTAL Jersey
- Employees
- DYN N/A
- MTAL N/A
- Industry
- DYN Medicinal Chemicals and Botanical Products
- MTAL Blank Checks
- Sector
- DYN Health Care
- MTAL Finance
- Exchange
- DYN Nasdaq
- MTAL Nasdaq
- Market Cap
- DYN 848.8M
- MTAL 690.2M
- IPO Year
- DYN 2020
- MTAL 2021
- Fundamental
- Price
- DYN $10.78
- MTAL $9.10
- Analyst Decision
- DYN Strong Buy
- MTAL Buy
- Analyst Count
- DYN 12
- MTAL 2
- Target Price
- DYN $47.73
- MTAL $14.75
- AVG Volume (30 Days)
- DYN 2.8M
- MTAL 427.6K
- Earning Date
- DYN 05-05-2025
- MTAL 04-29-2025
- Dividend Yield
- DYN N/A
- MTAL N/A
- EPS Growth
- DYN N/A
- MTAL N/A
- EPS
- DYN N/A
- MTAL N/A
- Revenue
- DYN N/A
- MTAL $340,736,000.00
- Revenue This Year
- DYN N/A
- MTAL $21.74
- Revenue Next Year
- DYN N/A
- MTAL $19.03
- P/E Ratio
- DYN N/A
- MTAL N/A
- Revenue Growth
- DYN N/A
- MTAL 114.30
- 52 Week Low
- DYN $6.36
- MTAL $7.69
- 52 Week High
- DYN $47.45
- MTAL $15.26
- Technical
- Relative Strength Index (RSI)
- DYN 57.30
- MTAL 48.82
- Support Level
- DYN $7.38
- MTAL $8.48
- Resistance Level
- DYN $8.01
- MTAL $8.93
- Average True Range (ATR)
- DYN 0.91
- MTAL 0.48
- MACD
- DYN 0.44
- MTAL 0.10
- Stochastic Oscillator
- DYN 92.47
- MTAL 89.24
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
About MTAL Metals Acquisition Limited
MAC Copper Ltd is a company focused on operating and acquiring metals and mining businesses in high-quality, stable jurisdictions that are critical in the electrification and decarbonization of the world-wide economy.